{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:40:24Z","timestamp":1792176024206,"version":"4.4.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s40122-018-0100-2","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T12:41:14Z","timestamp":1528202474000},"page":"163-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac"],"prefix":"10.1007","volume":"7","author":[{"given":"Fabiola","family":"Atzeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio Francesco","family":"Masala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"key":"100_CR1","first-page":"CD004768","volume":"2","author":"RA Moore","year":"2004","unstructured":"Moore RA, McQuay HJ, Derry P, et al. Single dose oral diclofenac for acute postoperative pain in adults. Cochrane Database Syst Rev. 2004;2:CD004768.","journal-title":"Cochrane Database Syst Rev."},{"key":"100_CR2","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1185\/03007995.2010.486301","volume":"26","author":"TJ Gan","year":"2010","unstructured":"Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010;26:1715\u201331.","journal-title":"Curr Med Res Opin"},{"key":"100_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/03009749609097226","volume":"102","author":"JR Vane","year":"1996","unstructured":"Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Scand J Rheum. 1996;102:9\u201321.","journal-title":"Scand J Rheum"},{"key":"100_CR4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0009-9236(99)70073-1","volume":"65","author":"I Tegeder","year":"1999","unstructured":"Tegeder I, Lotsch J, Krebs S, et al. Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state. Clin Pharmacol Ther. 1999;65:533\u201344.","journal-title":"Clin Pharmacol Ther"},{"key":"100_CR5","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/art.1780361017","volume":"36","author":"RH Wittenberg","year":"1993","unstructured":"Wittenberg RH, Willburger RE, Kleemeyer KS, et al. In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases. Arthritis Rheum. 1993;36:1444\u201350.","journal-title":"Arthritis Rheum"},{"key":"100_CR6","first-page":"18","volume":"80","author":"EC Ku","year":"1986","unstructured":"Ku EC, Lee W, Kothari HV, et al. Effect of diclofenac sodium on the arachidonic acid cascade. Am J Med. 1986;80:18\u201323.","journal-title":"Am J Med"},{"key":"100_CR7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1592\/phco.25.1.18.55618","volume":"25","author":"G Giagoudakis","year":"2005","unstructured":"Giagoudakis G, Markantonis SL. Relationships between the concentrations of prostaglandins and the nonsteroidal antiinflammatory drugs indomethacin, diclofenac, and ibuprofen. Pharmacotherapy. 2005;25:18\u201325.","journal-title":"Pharmacotherapy"},{"key":"100_CR8","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1096\/fj.01-0390rev","volume":"15","author":"I Tegeder","year":"2001","unstructured":"Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 2001;15:2057\u201372.","journal-title":"FASEB J"},{"key":"100_CR9","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","volume":"96","author":"TD Warner","year":"1999","unstructured":"Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclooxygenase- 1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA. 1999;96:7563\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"100_CR10","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1016\/S0021-9258(17)36794-7","volume":"269","author":"EA Dennis","year":"1994","unstructured":"Dennis EA. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem. 1994;269:13057\u201360.","journal-title":"J Biol Chem"},{"key":"100_CR11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF02535685","volume":"16","author":"CE Walsh","year":"1981","unstructured":"Walsh CE, Dechatelet LR, Thomas MJ, et al. Effect of phagocytosis and ionophores on release and metabolism of arachidonic acid from human neutrophils. Lipids. 1981;16:120\u20134.","journal-title":"Lipids"},{"key":"100_CR12","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0005-2760(87)90078-6","volume":"921","author":"HV Kothari","year":"1987","unstructured":"Kothari HV, Lee WH, Ku EC. An alternate mechanism for regulation of leukotriene production in leukocytes: studies with an anti-inflammatory drug, sodium diclofenac. Biochim Biophys Acta. 1987;921:502\u201311.","journal-title":"Biochim Biophys Acta"},{"key":"100_CR13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/gut.34.8.1133","volume":"34","author":"TJ Nevalainen","year":"1993","unstructured":"Nevalainen TJ, Gronroos JM, Kortesuo PT. Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis. Gut. 1993;34:1133\u20136.","journal-title":"Gut"},{"key":"100_CR14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/00365519709084587","volume":"57","author":"A Makela","year":"1997","unstructured":"Makela A, Kuusi T, Schroder T. Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro. Scand J Clin Lab Invest. 1997;57:401\u20137.","journal-title":"Scand J Clin Lab Invest"},{"key":"100_CR15","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.bbalip.2006.07.003","volume":"1761","author":"M Triggiani","year":"2006","unstructured":"Triggiani M, Granata F, Frattini A, et al. Activation of human inflammatory cells by secreted phospholipases A2. Biochim Biophys Acta. 2006;1761:1289\u2013300.","journal-title":"Biochim Biophys Acta"},{"key":"100_CR16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1107\/S0907444906003660","volume":"62","author":"N Singh","year":"2006","unstructured":"Singh N, Jabeen T, Sharma S, et al. Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7A\u00b0 resolution. Acta Crystallogr D. 2006;62:410\u20136.","journal-title":"Acta Crystallogr D"},{"key":"100_CR17","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1006\/bbrc.2001.5841","volume":"288","author":"CB Clish","year":"2001","unstructured":"Clish CB, Sun YP, Serhan CN. Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase\/LTB(4) dehydrogenase. Biochem Biophys Res Commun. 2001;288:868\u201374.","journal-title":"Biochem Biophys Res Commun"},{"key":"100_CR18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0014-2999(94)90398-0","volume":"251","author":"CR Tonussi","year":"1994","unstructured":"Tonussi CR, Ferreira SH. Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization. Eur J Pharmacol. 1994;251:173\u20139.","journal-title":"Eur J Pharmacol"},{"key":"100_CR19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0891-0618(95)00140-9","volume":"10","author":"L Fagni","year":"1996","unstructured":"Fagni L, Bockaert J. Effects of nitric oxide on glutamate-gated channels and other ionic channels. J Chem Neuroanatomy. 1996;10:231\u201340.","journal-title":"J Chem Neuroanatomy"},{"key":"100_CR20","first-page":"H423","volume":"270","author":"WM Armstead","year":"1996","unstructured":"Armstead WM. Role of ATP-sensitive K\u00fe channels in cGMP-mediated pial artery vasodilation. Am J Physiol. 1996;270:H423\u20136.","journal-title":"Am J Physiol"},{"key":"100_CR21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/sj.bjp.0704224","volume":"134","author":"AC Soares","year":"2001","unstructured":"Soares AC, Duarte ID. Dibutyryl-cyclic GMP induces peripheral antinociception via activation of ATP-sensitive K(\u00fe) channels in the rat PGE2-induced hyperalgesic paw. Br J Pharmacol. 2001;134:127\u201331.","journal-title":"Br J Pharmacol"},{"key":"100_CR22","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/j.lfs.2003.10.012","volume":"74","author":"DP Alves","year":"2004","unstructured":"Alves DP, Tatsuo MA, Leite R, et al. Diclofenac-induced peripheral antinociception is associated with ATP-sensitive K\u00fe channels activation. Life Sci. 2004;74:2577\u201391.","journal-title":"Life Sci"},{"key":"100_CR23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jchemneu.2017.08.006","volume":"87","author":"AA Kaplan","year":"2018","unstructured":"Kaplan AA, Yurt KK, Deniz \u00d6G, Altun G. Peripheral nerve and diclofenac sodium: Molecular and clinical approaches. J Chem Neuroanat. 2018;87:2\u201311.","journal-title":"J Chem Neuroanat."},{"key":"100_CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0021-5198(19)38076-X","volume":"35","author":"S Okuyama","year":"1984","unstructured":"Okuyama S, Aihara H. The mode of action of analgesic drugs in adjuvant arthritic rats as an experimental model of chronic inflammatory pain: possible central analgesic action of acidic nonsteroidal antiinflammatory drugs. Jpn J Pharmacol. 1984;35:95\u2013103.","journal-title":"Jpn J Pharmacol"},{"key":"100_CR25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0031-6989(85)90085-2","volume":"17","author":"P Sacerdote","year":"1985","unstructured":"Sacerdote P, Monza G, Mantegazza P, et al. Diclofenac and pirprofen modify pituitary and hypothalamic beta-endorphin concentrations. Pharmacol Res Commun. 1985;17:679\u201384.","journal-title":"Pharmacol Res Commun"},{"key":"100_CR26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0006-8993(92)91082-P","volume":"590","author":"RL Bjorkman","year":"1992","unstructured":"Bjorkman RL, Hedner T, Hallman KM, et al. Localization of the central antinociceptive effects of diclofenac in the rat. Brain Res. 1992;590:66\u201373.","journal-title":"Brain Res"},{"key":"100_CR27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/030006058401200205","volume":"12","author":"A Martini","year":"1984","unstructured":"Martini A, Bondiolotti GP, Sacerdote P, et al. Diclofenac increases beta-endorphin plasma concentrations. J Int Med Res. 1984;12:92\u20135.","journal-title":"J Int Med Res"},{"key":"100_CR28","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1002\/j.1552-4604.1996.tb00005.x","volume":"36","author":"R Bjorkman","year":"1996","unstructured":"Bjorkman R, Hallman KM, Hedner J, et al. Nonsteroidal antiinflammatory drug modulation of behavioral responses to intrathecal N-methyl-d-aspartate, but not to substance P and amino-methyl-isoxazole-propionic acid in the rat. J Clin Pharmacol. 1996;36:20S\u20136S.","journal-title":"J Clin Pharmacol"},{"key":"100_CR29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pain.2009.07.031","volume":"147","author":"X-D Dong","year":"2009","unstructured":"Dong X-D. The analgesic action of topical diclofenac may be mediated through peripheral NMDA receptor antagonism. Pain. 2009;147:36\u201345.","journal-title":"Pain"},{"key":"100_CR30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1124\/mol.61.1.7","volume":"61","author":"DJ Adamson","year":"2002","unstructured":"Adamson DJ, Frew D, Tatoud R, Wolf CR, Palmer CN. Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling. Mol Pharmacol. 2002;61:7\u201312.","journal-title":"Mol Pharmacol"},{"key":"100_CR31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0165-0173(94)00015-H","volume":"20","author":"J Gehrmann","year":"1995","unstructured":"Gehrmann J, Matsumoto Y, Kreutzeberg GW. Microglia: intrinsic immunoeffector cell of the brain. Brain Res Rev. 1995;20:269\u201387.","journal-title":"Brain Res Rev"},{"key":"100_CR32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/jpet.302.1.18","volume":"302","author":"R Yamazaki","year":"2002","unstructured":"Yamazaki R, Kusunoki N, Matsuzaki T, et al. Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells. J Pharmacol Exp Ther. 2002;302:18\u201325.","journal-title":"J Pharmacol Exp Ther"},{"key":"100_CR33","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0006-2952(03)00488-X","volume":"66","author":"HK Na","year":"2003","unstructured":"Na HK, Surh YJ. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation. Biochem Pharmacol. 2003;66:1381\u201391.","journal-title":"Biochem Pharmacol"},{"key":"100_CR34","first-page":"167","volume":"107","author":"A Sandri","year":"2016","unstructured":"Sandri A. Spinal anti-inflammatory action of diclofenac. Minerva Med. 2016;107:167\u201372.","journal-title":"Minerva Med"},{"key":"100_CR35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11010-009-0048-y","volume":"327","author":"SS Ayoub","year":"2009","unstructured":"Ayoub SS, Botting RM, Joshi AN, et al. Activation of macrophage peroxisome proliferator-activated receptor-gamma by diclofenac results in the induction of cyclooxygenase-2 protein and the synthesis of anti-inflammatory cytokines. Mol Cell Biochem. 2009;327:101\u201310.","journal-title":"Mol Cell Biochem"},{"key":"100_CR36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jcp.20061","volume":"201","author":"TM O\u2019Connor","year":"2004","unstructured":"O\u2019Connor TM, O\u2019Connell J, O\u2019Brien DI, et al. The role of substance P in inflammatory disease. J Cell Phys. 2004;201:167\u201380.","journal-title":"J Cell Phys"},{"key":"100_CR37","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/cyto.1995.0047","volume":"7","author":"I Tsuboi","year":"1995","unstructured":"Tsuboi I, Tanaka H, Nakao M, et al. Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: up-regulation of TNF, IFN-gamma and IL-2, in contrast to down-regulation of IL-6 production. Cytokine. 1995;7:372\u20139.","journal-title":"Cytokine"},{"key":"100_CR38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/PL00000261","volume":"50","author":"Y Henrotin","year":"2001","unstructured":"Henrotin Y, de Leval X, Mathy-Hartet M, et al. In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators. Inflamm Res. 2001;50:391\u20139.","journal-title":"Inflamm Res"},{"key":"100_CR39","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/bja\/88.6.797","volume":"88","author":"AM Mahdy","year":"2002","unstructured":"Mahdy AM, Galley HF, Abdel-Wahed MA, et al. Differential modulation of interleukin-6 and interleukin-10 by diclofenac in patients undergoing major surgery. Br J Anaesth. 2002;88:797\u2013802.","journal-title":"Br J Anaesth"},{"key":"100_CR40","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/BF01837915","volume":"44","author":"P Sacerdote","year":"1995","unstructured":"Sacerdote P, Carrabba M, Galante A, et al. Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti-inflammatory drugs indomethacin, diclofenac and naproxen. Inflamm Res. 1995;44:486\u201390.","journal-title":"Inflamm Res"},{"key":"100_CR41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02001912","volume":"41","author":"E Gonzalez","year":"1994","unstructured":"Gonzalez E, de la Cruz C, de Nicolas R, et al. Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis. Agents Actions. 1994;41:171\u20138.","journal-title":"Agents Actions"},{"key":"100_CR42","doi-asserted-by":"crossref","first-page":"8026","DOI":"10.1523\/JNEUROSCI.21-20-08026.2001","volume":"21","author":"N Voilley","year":"2001","unstructured":"Voilley N, de Weille J, Mamet J, et al. Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid sensing ion channels in nociceptors. J Neurosci. 2001;21:8026\u201333.","journal-title":"J Neurosci"},{"key":"100_CR43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1471-4159.2008.05412.x","volume":"106","author":"NA Dorofeeva","year":"2008","unstructured":"Dorofeeva NA, Barygin OI, Staruschenko A, et al. Mechanisms of non-steroid anti-inflammatory drugs action on ASICs expressed in hippocampal interneurons. J Neurochem. 2008;106:429\u201341.","journal-title":"J Neurochem"},{"key":"100_CR44","doi-asserted-by":"crossref","first-page":"10974","DOI":"10.1523\/JNEUROSCI.2619-04.2004","volume":"24","author":"NG Jones","year":"2004","unstructured":"Jones NG, Slater R, Cadiou H, et al. Acid-induced pain and its modulation in humans. J Neurosci. 2004;24:10974\u20139.","journal-title":"J Neurosci"},{"key":"100_CR45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/rheumatology\/39.suppl_2.3","volume":"39","author":"O Sangha","year":"2000","unstructured":"Sangha O. Epidemiology of rheumatic diseases. Rheumatology (Oxford). 2000;39:3\u201312.","journal-title":"Rheumatology (Oxford)"},{"key":"100_CR46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bmb\/lds038","volume":"105","author":"A Litwic","year":"2013","unstructured":"Litwic A, Edwards MH, Dennison EM, Cooper C. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013;105:185\u201399.","journal-title":"Br Med Bull"},{"key":"100_CR47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2008","unstructured":"Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58:26\u201335.","journal-title":"Part II. Arthritis Rheum."},{"issue":"4","key":"100_CR48","first-page":"19","volume":"55","author":"F Salaffi","year":"2003","unstructured":"Salaffi F. Pain in osteoarthritis: assessment and impact on the disability. Reumatismo. 2003;55(4):19\u201337.","journal-title":"Reumatismo"},{"issue":"4","key":"100_CR49","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF03324607","volume":"17","author":"F Salaffi","year":"2005","unstructured":"Salaffi F, Carotti M, Stancati A, Grassi W. Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls. Aging Clin Exp Res. 2005;17(4):255\u201363.","journal-title":"Aging Clin Exp Res"},{"key":"100_CR50","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3899\/jrheum.100759","volume":"38","author":"PJ Mease","year":"2011","unstructured":"Mease PJ, Hanna S, Frakes EP, Altman RD. Pain mechanisms in osteoarthritis: understanding the role of central pain and current approaches to its treatment. J Rheumatol. 2011;38:1546\u201351.","journal-title":"J Rheumatol"},{"key":"100_CR51","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/ar2178","volume":"9","author":"A Dray","year":"2007","unstructured":"Dray A, Read SJ. Arthritis and pain. Future targets to control osteoarthritis pain. Arthritis Res Ther. 2007;9:212.","journal-title":"Arthritis Res Ther"},{"key":"100_CR52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.addr.2006.01.011","volume":"58","author":"HG Schaible","year":"2006","unstructured":"Schaible HG, Schmelz M, Tegeder I. Pathophysiology and treatment of pain in joint disease. Adv Drug Deliv Rev. 2006;58:323\u201342.","journal-title":"Adv Drug Deliv Rev"},{"key":"100_CR53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4081\/reumatismo.2014.766","volume":"66","author":"F Salaffi","year":"2014","unstructured":"Salaffi F, Ciapetti A, Carotti M. The sources of pain in osteoarthritis: a pathophysiological review. Reumatismo. 2014;66:57\u201371.","journal-title":"Reumatismo."},{"key":"100_CR54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1749-6632.2002.tb04234.x","volume":"966","author":"HG Schaible","year":"2002","unstructured":"Schaible HG, Ebersberger A, von Banchet GS. Mechanisms of pain in arthritis. Ann N Y Acad Sci. 2002;966:343\u201354.","journal-title":"Ann N Y Acad Sci"},{"key":"100_CR55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/keh344","volume":"44","author":"CS Bonnet","year":"2005","unstructured":"Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology. 2005;44:7\u201316.","journal-title":"Rheumatology"},{"key":"100_CR56","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/rheumatology\/kem232","volume":"46","author":"M Porcheret","year":"2007","unstructured":"Porcheret M, Jordan K, Jinks C, Croft P. Primary care treatment of knee pain\u2014a survey in older adults. Rheumatology (Oxford). 2007;46:1694\u2013700.","journal-title":"Rheumatology (Oxford)"},{"key":"100_CR57","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.berh.2006.05.002","volume":"20","author":"P Juni","year":"2006","unstructured":"Juni P, Reichenbach S, Dieppe P. Osteoarthritis: rational approach to treating the individual. Best Pract Res Clin Rheumatol. 2006;20:721\u201340.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"100_CR58","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.clinthera.2011.10.019","volume":"33","author":"M Gore","year":"2011","unstructured":"Gore M, Sadosky A, Leslie D, Tai KS, Seleznick M. Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis. Clin Ther. 2011;33:1914\u201331.","journal-title":"Clin Ther"},{"key":"100_CR59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22:363\u201388.","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"100_CR60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejpain.2006.02.013","volume":"11","author":"JM Bjordal","year":"2007","unstructured":"Bjordal JM, Klovning A, Ljunggren AE, Slordal L. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials. Eur J Pain. 2007;11(2):125\u201338.","journal-title":"Eur J Pain."},{"key":"100_CR61","first-page":"1","volume":"12","author":"YF Chen","year":"2008","unstructured":"Chen YF, Jobanputra P, Barton P, et al. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess. 2008;12:1\u2013278.","journal-title":"Health Technol Assess"},{"key":"100_CR62","unstructured":"Chou R, McDonagh MS, Nakamoto E, Griffin J. Analgesics for osteoarthritis: an update of the 2006 comparative effectiveness review. Rockville: Agency for Healthcare Research and Quality (US), 2011."},{"issue":"10033","key":"100_CR63","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(16)30002-2","volume":"387","author":"BR da Costa","year":"2016","unstructured":"da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, J\u00fcni P, Trelle S. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2016;387(10033):2093\u2013105.","journal-title":"Lancet"},{"key":"100_CR64","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13075-015-0554-0","volume":"17","author":"A van Walsem","year":"2015","unstructured":"van Walsem A, Pandhi S, Nixon RM, Guyot P, Karabis A, Moore RA. Relative benefit\u2013risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis. Arthritis Res Ther. 2015;17:66.","journal-title":"Arthritis Res Ther"},{"key":"100_CR65","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","volume":"10","author":"A Latremoliere","year":"2009","unstructured":"Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10:895\u2013926.","journal-title":"J Pain"},{"key":"100_CR66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3959(98)00184-5","volume":"79","author":"RD Treede","year":"1999","unstructured":"Treede RD, Kenshalo DR, Gracely RH, Jones AK. The cortical representation of pain. Pain. 1999;79:105\u201311.","journal-title":"Pain"},{"key":"100_CR67","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/art.37739","volume":"65","author":"K Phillips","year":"2013","unstructured":"Phillips K, Clauw DJ. Central pain mechanism in the rheumatic diseases. Arth Rheum. 2013;65:291\u2013302.","journal-title":"Arth Rheum"},{"key":"100_CR68","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0009-9236(03)00165-6","volume":"74","author":"M Burian","year":"2003","unstructured":"Burian M, Tegeder I, Seegel M, Geisslinger G. Peripheral and central antihyperalgesic effects of diclofenac in a model of human inflammatory pain. Clin Pharmacol Ther. 2003;74:113\u201320.","journal-title":"Clin Pharmacol Ther"},{"key":"100_CR69","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/JPR.S36916","volume":"6","author":"V Vellani","year":"2013","unstructured":"Vellani V, Franchi S, Prandini M, Moretti S, Castelli M, Giacomoni C, Sacerdote P. Effects of NSAIDs and paracetamol (acetaminophen) on protein kinase C epsilon translocation and on substance P synthesis and release in cultured sensory neurons. J Pain Res. 2013;6:111\u201320.","journal-title":"J Pain Res."},{"key":"100_CR70","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/art.1780260811","volume":"26","author":"LE Kazis","year":"1983","unstructured":"Kazis LE, Meenan RF, Anderson JJ. Pain in the rheumatic diseases. Investigation of a key health status component. Arthritis Rheum. 1983;26:1017\u201322.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"100_CR71","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.berh.2015.04.016","volume":"29","author":"F Atzeni","year":"2015","unstructured":"Atzeni F, Masala IF, Salaffi F, Di Franco M, Casale R, Sarzi-Puttini P. Pain in systemic inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol. 2015;29(1):42\u201352.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"100_CR72","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/ard.2006.064287","volume":"66","author":"S Odegard","year":"2007","unstructured":"Odegard S, Finset A, Mowinckel P, Kvien TK, Uhlig T. Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis. Ann Rheum Dis. 2007;66:1195\u2013201.","journal-title":"Ann Rheum Dis"},{"key":"100_CR73","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nrrheum.2012.24","volume":"8","author":"F Atzeni","year":"2012","unstructured":"Atzeni F, Sarzi-Puttini P. Rheumatoid arthritis: why wait? Explaining delays in seeking therapy for early arthritis. Nat Rev Rheumatol. 2012;8:190\u20131.","journal-title":"Nat Rev Rheumatol"},{"key":"100_CR74","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3899\/jrheum.130493","volume":"40","author":"ML Andersson","year":"2013","unstructured":"Andersson ML, Svensson B, Bergman S. Chronic widespread pain in patients with rheumatoid arthritis and the relation between pain and disease activity measures over the first 5 years. J Rheumatol. 2013;40:1977\u201385.","journal-title":"J Rheumatol"},{"key":"100_CR75","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.berh.2010.01.011","volume":"25","author":"F Atzeni","year":"2011","unstructured":"Atzeni F, Cazzola M, Benucci M, Di Franco M, Salaffi F, Sarzi-Puttini P. Chronic widespread pain in the spectrum of rheumatological diseases. Best Pract Res Clin Rheumatol. 2011;25:165\u201371.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"100_CR76","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","volume":"152","author":"CJ Woolf","year":"2010","unstructured":"Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2010;152:S2\u201315.","journal-title":"Pain"},{"key":"100_CR77","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1002\/art.30564","volume":"63","author":"SP Raychaudhuri","year":"2011","unstructured":"Raychaudhuri SP, Raychaudhuri SK, Atkuri KR, Herzenberg LA, Herzenberg LA. Nerve growth factor: a key local regulator in the pathogenesis of inflammatory arthritis. Arthritis Rheum. 2011;63:3243\u201352.","journal-title":"Arthritis Rheum"},{"key":"100_CR78","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.2009.05301.x","volume":"1193","author":"HG Schaible","year":"2010","unstructured":"Schaible HG, von Banchet GS, Boettger MK, et al. The role of proinflammatory cytokines in the generation and maintenance of joint pain. Ann N Y Acad Sci. 2010;1193:60\u20139.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"100_CR79","first-page":"731","volume":"31","author":"P Sarzi-Puttini","year":"2013","unstructured":"Sarzi-Puttini P, Atzeni F, Lanata L, Bagnasco M. Efficacy of ketoprofen vs. ibuprofen and diclofenac: a systematic review of the literature and meta-analysis. Clin Exp Rheumatol. 2013;31(5):731\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"100_CR80","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(97)01300-7","volume":"350","author":"M Boers","year":"1997","unstructured":"Boers M, Verhoeven AC, Markusse HM, et al. Randomized comparison of combined step-down prednisolone, methotrexate, and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet. 1997;350:309\u201318.","journal-title":"Lancet"},{"issue":"Suppl 5","key":"100_CR81","doi-asserted-by":"crossref","first-page":"v22","DOI":"10.1093\/rheumatology\/kes115","volume":"51","author":"P Emery","year":"2012","unstructured":"Emery P. Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatment. Rheumatology. 2012;51(Suppl 5):v22\u201330.","journal-title":"Rheumatology"},{"key":"100_CR82","doi-asserted-by":"crossref","unstructured":"Ramiro S, Radner H, van der Heijde D, et al. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database Syst Rev. 2011;(10):CD008886.","DOI":"10.1002\/14651858.CD008886.pub2"},{"key":"100_CR83","doi-asserted-by":"crossref","unstructured":"Wienecke T, Gotzsche PC. Paracetamol vs nonsteroidal anti-inflammatory drugs for rheumatoid arthritis. Cochrane Database Syst Rev. 2004;1:CD003789.","DOI":"10.1002\/14651858.CD003789.pub2"},{"key":"100_CR84","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/rheumatology\/kes032","volume":"51","author":"SL Whittle","year":"2012","unstructured":"Whittle SL, Colebatch AN, Buchbinder R, et al. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e initiative. Rheumatology (Oxford). 2012;51:1416\u201325.","journal-title":"Rheumatology (Oxford)"},{"key":"100_CR85","doi-asserted-by":"crossref","unstructured":"Richards BL, Whittle SL, Buchbinder R. Neuromodulators for pain management in rheumatoid arthritis. Cochrane Database Syst Rev. 2012;1:CD008921.","DOI":"10.1002\/14651858.CD008921.pub2"},{"issue":"4","key":"100_CR86","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1756285616684494","volume":"10","author":"S Joshi","year":"2017","unstructured":"Joshi S, Rapoport AM. Diclofenac potassium for oral solution (CAMBIA\u00ae) in the acute management of a migraine attack: clinical evidence and practical experience. Ther Adv Neurol Disord. 2017;10(4):217\u201326.","journal-title":"Ther Adv Neurol Disord."},{"key":"100_CR87","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1080\/03007995.2017.1352497","volume":"33","author":"M Hagen","year":"2017","unstructured":"Hagen M, Baker M. Skin penetration and tissue permeation after topical administration of diclofenac. Curr Med Res Opin. 2017;33:1623\u201334.","journal-title":"Curr Med Res Opin"},{"key":"100_CR88","doi-asserted-by":"crossref","unstructured":"Derry S, Wiffen PJ, Kalso EA, et al. Topical analgesics for acute and chronic pain in adults\u2014an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017;5:CD008609.","DOI":"10.1002\/14651858.CD012592"},{"key":"100_CR89","doi-asserted-by":"crossref","unstructured":"Coxib and traditional NSAID Trialists\u2019 (CNT) Collaboration Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382:769\u201379.","DOI":"10.1016\/S0140-6736(13)60900-9"},{"key":"100_CR90","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/pds.1962","volume":"19","author":"HW Kuo","year":"2010","unstructured":"Kuo HW, Tsai SS, Tiao MM, Liu YC, Lee IM, Yang CY. Analgesic use and the risk for progression of chronic kidney disease. Pharmacoepidemiol Drug Saf. 2010;19:745\u201351.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"100_CR91","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2174\/1570161114666160728093323","volume":"14","author":"C Kontogiorgis","year":"2016","unstructured":"Kontogiorgis C, Valikeserlis I, Hadjipavlou-Litina D, Nena E, Constantinidis TC. Use of non-selective non-steroidal anti-inflammatory drugs in relation to cardiovascular events. A systematic pharmacoepidemiological review. Curr Vasc Pharmacol. 2016;14:502\u201313.","journal-title":"Curr Vasc Pharmacol."},{"key":"100_CR92","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","volume":"96","author":"TD Warner","year":"1999","unstructured":"Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci. 1999;96:7563\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"100_CR93","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/00002018-200427060-00005","volume":"27","author":"JR Laporte","year":"2004","unstructured":"Laporte JR, Ibanez L, Vidal X, Vendrell L, Leone R. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf. 2004;27:411\u201320.","journal-title":"Drug Saf"},{"key":"100_CR94","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s40265-015-0392-z","volume":"75","author":"R Altman","year":"2015","unstructured":"Altman R, Bosch B, Brune K, Patrignani P, Young C. Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology. Drugs. 2015;75:859\u201377.","journal-title":"Drugs."},{"issue":"12","key":"100_CR95","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1185\/030079905X75069","volume":"21","author":"C Zerbini","year":"2005","unstructured":"Zerbini C, Ozturk ZE, Grifka J, Maini M, Nilganuwong S, Morales R, et al. Efficacy of etoricoxib 60\u00a0mg\/day and diclofenac 150\u00a0mg\/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study. Curr Med Res Opin. 2005;21(12):2037\u201349.","journal-title":"Curr Med Res Opin"},{"issue":"7","key":"100_CR96","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/AJP.0b013e31826f9a71","volume":"29","author":"Nathalie A. Roussel","year":"2013","unstructured":"Roussel NA, Nijs J, Meeus M, Mylius V, Fayt C, Oostendorp R. Central sensitization and altered central pain processing in chronic low back pain: fact or myth? Clin J Pain. 2013;29(7):625\u201338.","journal-title":"The Clinical Journal of Pain"},{"key":"100_CR97","first-page":"610","volume":"10","author":"P Pantziarka","year":"2016","unstructured":"Pantziarka P, Sukhatme V, Bouche G, Meheus L, Sukhatme VP. Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent. Ecancermedicalscience. 2016;10:610.","journal-title":"Ecancermedicalscience."},{"issue":"Suppl 2","key":"100_CR98","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jdv.14092","volume":"31","author":"E Stockfleth","year":"2017","unstructured":"Stockfleth E. The importance of treating the field in actinic keratosis. J Eur Acad Dermatol Venereol. 2017;31(Suppl 2):8\u201311.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"100_CR99","first-page":"1011","volume":"9","author":"A Maltusch","year":"2011","unstructured":"Maltusch A, R\u00f6wert-Huber J, Matthies C, Lange-Asschenfeldt S, Stockfleth E. Modes of action of diclofenac 3%\/hyaluronic acid 2.5% in the treatment of actinic keratosis. J Dtsch Dermatol Ges. 2011;9(12):1011\u20137.","journal-title":"J Dtsch Dermatol Ges."},{"issue":"3","key":"100_CR100","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1021\/acs.inorgchem.6b02553","volume":"56","author":"FP Intini","year":"2017","unstructured":"Intini FP, Zajac J, Novohradsky V, Saltarella T, Pacifico C, Brabec V, Natile G, Kasparkova J. Novel antitumor platinum(II) conjugates containing the nonsteroidal anti-inflammatory agent diclofenac: synthesis and dual mechanisms of antiproliferative effects. Inorg Chem. 2017;56(3):1483\u201397.","journal-title":"Inorg Chem"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-018-0100-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-018-0100-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-018-0100-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:40:24Z","timestamp":1724413224000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-018-0100-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["100"],"URL":"https:\/\/doi.org\/10.1007\/s40122-018-0100-2","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,5]]},"assertion":[{"value":"30 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}